42390
73211
ITI Pharma and Healthcare Fund - Dir (G)
22.34
5.40
-1.20
3.73
7.15
2.84
13.87
7
1.83
22.34
ITI Pharma and Healthcare Fund - Dir (G)
1.73
20.06
1.11
3.5
3 Years

SIP TrendupInvest in Mutual Funds at 0 Transaction cost

Start Investing
  • NAV

    18.07

    29 May 2026

  • -1.13%

     1 Day

  • 22.34%

    3Y CAGR returns

Note: Data shown is for Direct Plan. Our Platform offers Regular Plans only. Returns may differ due to expense ratio differences.
One click to compare funds with our smart tool—analyze returns & more! Compare
  • ₹ 500

    Min SIP
  • ₹ 5000

    Min Lumpsum
  • 3.11%

    Expense Ratio
  • 2

    Rating
  • 230 Cr

    Fund Size
  • 4 Years

    Fund Age

SIP Calculator

Yr
  • Invested Amount
  • ₹ 00
  • Wealth Gained
  • ₹ 00
  • Expected Amount
  • ₹ 00
Yr
  • Invested Amount
  • ₹ 00
  • Wealth Gained
  • ₹ 00
  • Expected Amount
  • ₹ 00

Returns and Ranks ( as on 29 May 2026 )

  • 1Y Returns
  • 3Y Returns
  • 5Y Returns
  • MAX Returns
  • Trailing Returns
  • 5.40%
  • 22.34%
  • 13.87
  • -1.62Alpha
  • 4.74SD
  • 0.92Beta
  • 0.80Sharpe
  • Exit Load
  • If redeemed/Switched out on or before 3 Months from the date of allotment Exit Load is 0.50% Exit Load after completion of 3 months - NIL
  • Tax implication
  • Returns redeemed within a year are taxed at 20%, while those held longer incur a 12.5% LTCG tax on gains over Rs 1.25 lakh per financial year.
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

Animesh Singh

Low Low to
moderate
Moderate Moderately
High
High Very
High
  • Address :
  • ITI House 36, Dr.R.K.Shirodkar Marg, Parel Mumbai - 400012.
    • Contact :
    • +91022-66214999
    • Email ID :
    • mfassist@itiorg.com

FAQs

ITI Pharma and Healthcare Fund - Dir (G) has delivered 18.01% since inception

The NAV of ITI Pharma and Healthcare Fund - Dir (G) is ₹15.5642 as of 29 May 2026

The expense ratio of ITI Pharma and Healthcare Fund - Dir (G) is 3.11 % as of 29 May 2026

The AUM of ITI Pharma and Healthcare Fund - Dir (G) 156.65 CR as of 29 May 2026

The minimum SIP amount of ITI Pharma and Healthcare Fund - Dir (G) is 500

The top stock holdings of ITI Pharma and Healthcare Fund - Dir (G) are

  1. Sun Pharma.Inds. - 12.40%
  2. Divi's Lab. - 8.83%
  3. Apollo Hospitals - 6.25%
  4. Max Healthcare - 5.22%
  5. Torrent Pharma. - 4.82%

The top sectors ITI Pharma and Healthcare Fund - Dir (G) has invested in are

  1. Pharmaceuticals & Biotech - 75.47%
  2. Healthcare Services - 21.3%
  3. Chemicals & Petrochemical - 1.5%
  4. Fertilisers & Agrochemica - 1.25%
  5. Cash & Others - 0.48%

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form